awmsg logo



aviptadil/phentolamine (Invicorp®)


Reference No. 2972

Publication date:
28/11/2016


Appraisal information

aviptadil/phentolamine (Invicorp®) 25 micrograms / 2 mg solution for injection


Company: Evolan Pharma AB
BNF category: Obstetrics, gynaecology, and urinary-tract disorders
NMG meeting date: 05/10/2016
AWMSG meeting date: 09/11/2016
   
   
Submission Type: Full Submission
Status: Superseded
Advice No: 3216
Ministerial ratification: 25/11/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

ADVICE SUPERSEDED BY AWMSG ADVICE No: 1117 ISSUED JULY 2017 (Refer to AWMSG website for full guidance on AWMSG recommendations, including any specific restrictions on the use of the technology).
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download